Clobazam 10 MG Oral Tablet — RxCUI 199450
RxNorm drug concept · Semantic clinical drug
RxCUI 199450
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
42 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199450
Official nameClobazam 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped25
Package NDCs mapped42
Reported Medicaid activity (SDUD)308,098 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clobazam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Clobazam is prescribed as an add-on seizure medication for people with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy. It works alongside other seizure medicines — it's n...
- It's best to avoid alcohol completely while you're taking clobazam. Alcohol is itself a sedative, and when combined with clobazam it can boost clobazam levels in your blood by abou...
- Is it okay to have a drink of alcohol while I'm on clobazam?
- The most common things people notice are drowsiness, low energy, drooling, constipation, and sometimes fever or irritability. Drowsiness is most common early on and often improves...
🕸️ Concept Web — How Clobazam 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clobazam 10 MG Oral Tablet
RxCUI 199450 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clobazam
21241IN
-
Clobazam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Onfi
1191051BN
-
Onfi
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clobazam Oral Tablet
371560SCDF -
Clobazam Oral Product
1163749SCDG -
Clobazam Pill
1163750SCDG -
Clobazam Oral Tablet [Onfi]
1191053SBDF -
Onfi Oral Product
1191054SBDG -
Onfi Pill
1191055SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Clobazam Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clobazam 10 MG
331727SCDC -
Clobazam 10 MG Oral Tablet [Onfi]
1191056SBD -
Clobazam 10 MG [Onfi]
1191052SBDC
-
Clobazam 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clobazam 10 MG
SCDC · 331727 -
Clobazam Oral Tablet
SCDF · 371560 -
Clobazam Oral Product
SCDG · 1163749 -
Clobazam Pill
SCDG · 1163750
Brand-Name Concepts
-
Clobazam 10 MG Oral Tablet [Onfi]
SBD · 1191056 -
Clobazam 10 MG [Onfi]
SBDC · 1191052 -
Clobazam Oral Tablet [Onfi]
SBDF · 1191053 -
Onfi Oral Product
SBDG · 1191054 -
Onfi Pill
SBDG · 1191055 -
Onfi
BN · 1191051
📦 FDA Products & Package NDCs
25 products · 42 package NDCs
42 package NDCs map to RxCUI 199450 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00832-0580-11 | 100 TABLET in 1 BOTTLE (0832-0580-11) | Clobazam | Upsher-Smith Laboratories, LLC | 2018-10-22 |
| 00832-0581-11 | 100 TABLET in 1 BOTTLE (0832-0581-11) | Clobazam | Upsher-Smith Laboratories, LLC | 2018-10-22 |
| 16714-0887-01 | 100 TABLET in 1 BOTTLE (16714-887-01) | Clobazam | NorthStar RxLLC | 2018-11-12 |
| 16714-0888-01 | 100 TABLET in 1 BOTTLE (16714-888-01) | Clobazam | NorthStar RxLLC | 2018-11-12 |
| 31722-0639-01 | 100 TABLET in 1 BOTTLE (31722-639-01) | Clobazam | Camber Pharmaceuticals, Inc. | 2018-10-22 |
| 31722-0639-31 | 10 BLISTER PACK in 1 CARTON (31722-639-31) / 10 TABLET in 1... | Clobazam | Camber Pharmaceuticals, Inc. | 2018-10-22 |
| 31722-0640-01 | 100 TABLET in 1 BOTTLE (31722-640-01) | Clobazam | Camber Pharmaceuticals, Inc. | 2018-10-22 |
| 31722-0640-31 | 10 BLISTER PACK in 1 CARTON (31722-640-31) / 10 TABLET in 1... | Clobazam | Camber Pharmaceuticals, Inc. | 2018-10-22 |
| 42571-0315-01 | 100 TABLET in 1 BOTTLE (42571-315-01) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0315-05 | 500 TABLET in 1 BOTTLE (42571-315-05) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0315-11 | 100 BLISTER PACK in 1 CARTON (42571-315-11) / 10 TABLET in... | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0315-30 | 30 TABLET in 1 BOTTLE (42571-315-30) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0315-90 | 90 TABLET in 1 BOTTLE (42571-315-90) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0315-91 | 100 BLISTER PACK in 1 CARTON (42571-315-91) / 10 TABLET in... | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0316-01 | 100 TABLET in 1 BOTTLE (42571-316-01) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0316-11 | 100 BLISTER PACK in 1 CARTON (42571-316-11) / 10 TABLET in... | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0316-30 | 30 TABLET in 1 BOTTLE (42571-316-30) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0316-90 | 90 TABLET in 1 BOTTLE (42571-316-90) | Clobazam | Micro Labs Limited | 2019-04-02 |
| 42571-0316-91 | 100 BLISTER PACK in 1 CARTON (42571-316-91) / 10 TABLET in... | Clobazam | Micro Labs Limited | 2019-04-02 |
| 51407-0585-01 | 100 TABLET in 1 BOTTLE (51407-585-01) | Clobazam | Golden State Medical Supply, Inc. | 2024-07-30 |
| 51407-0586-01 | 100 TABLET in 1 BOTTLE (51407-586-01) | Clobazam | Golden State Medical Supply, Inc. | 2024-07-30 |
| 51672-4202-01 | 100 TABLET in 1 BOTTLE (51672-4202-1) | Clobazam | Taro Pharmaceuticals U.S.A., Inc. | 2018-10-22 |
| 51672-4203-01 | 100 TABLET in 1 BOTTLE (51672-4203-1) | Clobazam | Taro Pharmaceuticals U.S.A., Inc. | 2018-10-22 |
| 60687-0423-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-423-21) / 1 TABL... | Clobazam | American Health Packaging | 2019-01-17 |
| 67386-0313-21 | 1 BOTTLE in 1 CARTON (67386-313-21) / 120 mL in 1 BOTTLE | Onfi | Lundbeck Pharmaceuticals LLC | 2012-12-14 |
| 67386-0314-01 | 1 BOTTLE in 1 CARTON (67386-314-01) / 100 TABLET in 1 BOTTL... | Onfi | Lundbeck Pharmaceuticals LLC | 2013-12-10 |
| 67386-0315-01 | 1 BOTTLE in 1 CARTON (67386-315-01) / 100 TABLET in 1 BOTTL... | Onfi | Lundbeck Pharmaceuticals LLC | 2013-12-10 |
| 67877-0664-01 | 1 BOTTLE in 1 CARTON (67877-664-01) / 100 TABLET in 1 BOTTL... | Clobazam | Ascend Laboratories, LLC | 2023-10-18 |
| 67877-0664-05 | 500 TABLET in 1 BOTTLE (67877-664-05) | Clobazam | Ascend Laboratories, LLC | 2023-10-18 |
| 67877-0664-33 | 1 BLISTER PACK in 1 CARTON (67877-664-33) / 10 TABLET in 1... | Clobazam | Ascend Laboratories, LLC | 2023-10-18 |
| 67877-0665-01 | 100 CARTON in 1 CONTAINER (67877-665-01) / 1 TABLET in 1 CA... | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 67877-0665-05 | 500 TABLET in 1 CONTAINER (67877-665-05) | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 67877-0665-33 | 10 CARTON in 1 BLISTER PACK (67877-665-33) / 1 TABLET in 1... | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 67877-0666-01 | 100 CARTON in 1 CONTAINER (67877-666-01) / 1 TABLET in 1 CA... | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 67877-0666-05 | 500 TABLET in 1 CONTAINER (67877-666-05) | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 67877-0666-33 | 10 CARTON in 1 BLISTER PACK (67877-666-33) / 1 TABLET in 1... | Clobazam | Ascend Laboratories, LLC | 2019-09-07 |
| 68180-0157-01 | 1 BOTTLE in 1 CARTON (68180-157-01) / 100 TABLET in 1 BOTTL... | Clobazam | Lupin Pharmaceuticals, Inc. | 2019-05-08 |
| 68180-0158-01 | 1 BOTTLE in 1 CARTON (68180-158-01) / 100 TABLET in 1 BOTTL... | Clobazam | Lupin Pharmaceuticals, Inc. | 2019-05-08 |
| 69238-1305-01 | 100 TABLET in 1 BOTTLE (69238-1305-1) | CLOBAZAM | Amneal Pharmaceuticals NY LLC | 2018-10-22 |
| 69238-1306-01 | 100 TABLET in 1 BOTTLE (69238-1306-1) | CLOBAZAM | Amneal Pharmaceuticals NY LLC | 2018-10-22 |
| 72205-0047-91 | 1 BOTTLE in 1 CARTON (72205-047-91) / 100 TABLET in 1 BOTTL... | CLOBAZAM | Novadoz Pharmaceuticals LLC | 2022-06-10 |
| 72205-0048-91 | 1 BOTTLE in 1 CARTON (72205-048-91) / 100 TABLET in 1 BOTTL... | CLOBAZAM | Novadoz Pharmaceuticals LLC | 2022-06-10 |
Observed labelers:
Micro Labs Limited (11) ·
Ascend Laboratories, LLC (9) ·
Camber Pharmaceuticals, Inc. (4) ·
Lundbeck Pharmaceuticals LLC (3) ·
Amneal Pharmaceuticals NY LLC (2) ·
Golden State Medical Supply, Inc. (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.